Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy
Open Access
- 6 December 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (4), 856-868
- https://doi.org/10.1093/ndt/gfs466
Abstract
BackgroundCalcific uraemic arteriolopathy (CUA) or calciphylaxis is a rare, life-threatening disease predominantly occurring in patients with end-stage renal disease. Its pathogenesis has been suggested to include ectopic osteogenesis in soft tissue and the vasculature associated with extracellular matrix (ECM) remodelling.MethodsTo gain further insights into the pathogenesis of CUA, we performed systematic analyses of skin specimens obtained from seven CUA patients including histology, immunohistochemistry, electron microscopy, electron dispersive X-ray analysis (EDX) and quantitative real-time RT-PCR. Skin specimens of (i) seven patients without chronic kidney disease and without CUA and (ii) seven dialysis patients without CUA served as controls.ResultsIn the CUA skin lesions, we observed a significant upregulation of bone morphogenic protein 2 (BMP-2), its target gene Runx2 and its indirect antagonist sclerostin. Furthermore, we detected an increased expression of inactive uncarboxylated matrix Gla protein (Glu-MGP). The upregulation of osteogenesis-associated markers was accompanied by an increased expression of osteopontin, fibronectin, laminin and collagen I indicating an extensive remodelling of the subcutaneous ECM. EDX analysis revealed calcium/phosphate accumulations in the subcutis of all CUA patients with a molar ratio of 1.68 ± 0.06 matching that of hydroxyapatite mineral. Widespread media calcification in cutaneous arterioles was associated with destruction of the endothelial layer and partial exfoliation of the endothelial cells (ECs). CD31 immunostaining revealed aggregates of ECs contributing to intraluminal obstruction and consecutive malperfusion resulting in the clinical picture of ulcerative necrosis in all seven patients.ConclusionsOur data indicate that CUA is an active osteogenic process including the upregulation of BMP-2 signalling, hydroxyapatite deposition and extensive matrix remodelling of the subcutis.Keywords
This publication has 52 references indexed in Scilit:
- Simulation-Based Sodium Thiosulfate Dosing Strategies for the Treatment of CalciphylaxisClinical Journal of the American Society of Nephrology, 2011
- Calciphylaxis: a still unmet challengeJournal of Nephrology, 2011
- Calcific Uremic Arteriolopathy: Pathophysiology, Reactive Oxygen Species and Therapeutic ApproachesOxidative Medicine and Cellular Longevity, 2010
- Calcific uraemic arteriolopathy: an updateCurrent Opinion in Nephrology and Hypertension, 2008
- Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfateInternational Urology and Nephrology, 2008
- Bone Morphogenetic Proteins in Vascular CalcificationCirculation Research, 2005
- A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapiesClinical Nephrology, 2003
- Matrix GLA Protein, a Regulatory Protein for Bone Morphogenetic Protein-2Journal of Biological Chemistry, 2002
- Cutaneous necrosis from calcific uremic arteriolopathy.American Journal of Kidney Diseases, 1998
- CALCIFYING PANNICULITIS WITH FAT AND SKIN NECROSIS IN A CASE OF URÆMIA WITH AUTONOMOUS HYPERPARATHYROIDISMThe Lancet, 1968